ACE inhibitors are beneficial for many patients at risk for heart disease

December 1999

A new landmark study shows that ACE inhibitors are beneficial for many patients at risk for heart disease.

We already know they improve survival in patients with systolic heart failure...or a recent MI.

Now there's evidence the ACE inhibitor ramipril (Altace) reduces morbidity and mortality for a broad spectrum of patients with atherosclerosis or diabetes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote